11月，马萨诸塞州先进细胞技术公司同意把胚胎干细胞应用于治疗斯特格病变黄斑营养不良的临床实验。这种疾病可以破坏儿童的视网膜细胞。
In November Advanced cell Technology, of Massachusetts, won approval for the trial of a treatment for Stargardt's macular dystrophy, a disease that destroys retinal cells in children.
11月，马萨诸塞州先进细胞技术公司同意把胚胎干细胞应用于治疗斯特格病变黄斑营养不良的临床实验。这种疾病可以破坏儿童的视网膜细胞。
In November Advanced cell Technology, of Massachusetts, won approval for the trial of a treatment for Stargardt's macular dystrophy, a disease that destroys retinal cells in children.
应用推荐